Explore innovative approaches targeting PRAME+ cancers with Cedrik M. Britten, MD. Learn about the clinical development of TCR T-cell therapies and bispecific T-cell engagers. Learn more and register: https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit
